Yongxia Shi - Concepedia

Author

Yongxia Shi

State Key Laboratory of Respiratory Disease ORCID

Also Known As

H. Wang, Jingxian Zhao, SHI Yong‐xia, Shi Yong-Xia, Shi Yongxia, Y. Shi, Yong-Xia Shi, Yong-xia Shi, Yongxia Shi, Yong‐Xia Shi

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

State Key Laboratory of Respiratory Disease Guangzhou Medical University First Affiliated Hospital of Guangzhou Medical University Sun Yat-sen University Shanghai Customs College

About

Yongxia Shi is an author at State Key Laboratory of Respiratory Disease specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Natural Sciences	3	3	50
3	Public Health	1	1	488
4	Biochemistry	1	1	22
5	Biology	1	1	13

Yongxia Shi

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins Tommy Tsan‐Yuk Lam, Na Jia, Yawei Zhang, Nature	2020	2K
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Runfeng Li, Yunlong Hou, Jicheng Huang, Pharmacological Research MedicineNovel CoronavirusImmunologyAntiviral ResponseAntiviral Drug Development	2020	667
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment Jing Sun, Zhen Zhuang, Jian Zheng, Cell VaccinationBroadly Useful ModelInfectious Disease ModellingCovid-19 PandemicImmunology	2020	488
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient Jing Sun, Airu Zhu, Heying Li, Emerging Microbes & Infections Viral DiagnosticsEmerging Infectious DiseasesRespiratory DiseasesCovid-19 PandemicImmunology	2020	364
Mapping and role of T cell response in SARS-CoV-2–infected mice Zhen Zhuang, Xiaomin Lai, Jing Sun, The Journal of Experimental Medicine	2021	184
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway Qinhai Ma, Weiqi Pan, Runfeng Li, Pharmacological Research InflammationImmunologyViral PathogenesisAntiviral Drug DevelopmentVirology	2020	122
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway Qinhai Ma, Runfeng Li, Weiqi Pan, Phytomedicine InflammationAnti-inflammatoryNovel CoronavirusImmunologyPharmacology	2020	108
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo Zhaoyong Zhang, Eric Zeng, Lu Zhang, Cell Discovery	2021	64
Expression of vip1/vip2 genes in Escherichia coli and Bacillus thuringiensis and the analysis of their signal peptides Yongxia Shi, Wei Xu, Meijin Yuan, Journal of Applied Microbiology	2004	54
Cu-Based Tandem Catalysts for Electrochemical CO<sub>2</sub> Reduction Yongxia Shi, Hou Man, Junjun Li, Acta Physico-Chimica Sinica	2022	42

Page 1